Recent Updates
Recently added Catalysts
IART Positive Sentiment

Integra LifeSciences Continues to Make Progress on Its ESG Strategy

Key Takeaway: Integra LifeSciences has released its latest Environmental, Social, and Governance (ESG) report, showcasing progress in ESG performance since establishing its strategy three years ago. The report includes efforts in reducing greenhouse gas emissions, promoting diversity and inclusion, and strengthening governance practices. CEO Jan De Witte emphasized the company's commitment to creating healthier environments for patients and employees alike. The report aligns with major external guidelines for transparency and accountability.
Price reaction · baseline $20.85 (2024-08-20 close) · hit after-hours · clean, no other IART news in the window
day 0 close · peak
+0.9%

Market Sentiment Analysis

POSITIVE FACTORS

  • Integra LifeSciences made significant progress on its ESG commitments.
  • The company is focusing on innovation to enhance patient outcomes.
  • Continued improvements in diversity and inclusion within the workforce.

Full Press Release Details

PRINCETON, N.J., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Company (NASDAQ: IART), a leading global medical technology company, today issued its latest Environmental, Social and Governance (ESG) report. The report highlights the company’s 2023 ESG performance and ongoing efforts against the ESG strategy and roadmap established three years ago.
“Innovating treatment pathways to advance patient outcomes and set new standards of care is work that matters to our Integra colleagues around the world and is what drives us each and every day,” said Jan De Witte, president and chief executive officer, Integra LifeSciences. “We are pleased with the advances we have made to meet our ESG commitments and ambitions as we play our part to create healthier people, a healthier workplace and a healthier world.”
Integra’s ESG report includes the past year’s highlights in key areas:
Environmental – Recalculated Scope 1, 2 and 3 emissions and partnered with an external consultant to conduct energy assessments at highest energy usage locations to identify energy reduction opportunities and improve greenhouse gas footprint
Social – Bolstered diversity and inclusion efforts by adding a new employee resource group and furthering our focus on early-in-career talent by providing support and hands-on experience to diverse college students and graduates
Governance – Revised Code of Conduct and continued to strengthen anti-bribery and corruption program through ongoing training curriculums and programs
Integra prepared its ESG report in alignment with external guidelines and measurement frameworks, including the Global Reporting Index and the Sustainability Accounting Standards Board Index.
Read the full report here.
At Integra LifeSciences, we are driven by our purpose of restoring patients’ lives. We innovate treatment pathways to advance patient outcomes and set new standards of surgical, neurologic, and regenerative care. We offer a comprehensive portfolio of high quality, leadership brands. For the latest news and information about Integra and its products, please visit investor.integralife.com.

Frequently Asked Questions

What does Integra's latest ESG report highlight?

The report emphasizes Integra's 2023 ESG performance and ongoing commitments.

How does Integra address environmental impact?

Integra recalculated its emissions and conducted energy assessments for reductions.

What social initiatives has Integra implemented?

The company enhanced diversity efforts by creating a new employee resource group.

What governance improvements did Integra make?

Integra revised its Code of Conduct and strengthened anti-bribery training.

Which frameworks did Integra's ESG report follow?

The report aligns with the Global Reporting Index and Sustainability Accounting Standards.

Last updated: Aug 21, 2024